Cargando…
Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis
OBJECTIVE: There is considerable uncertainty regarding the optimal use of rifampicin for the treatment of tuberculous (TB) meningitis. A pharmacokinetic modeling and simulation study of rifampicin concentrations in cerebrospinal fluid (CSF) during TB meningitis treatment was performed in this study....
Autores principales: | Mezochow, Alyssa, Thakur, Kiran T., Zentner, Isaac, Subbian, Selvakumar, Kagan, Leonid, Vinnard, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6666413/ https://www.ncbi.nlm.nih.gov/pubmed/31051278 http://dx.doi.org/10.1016/j.ijid.2019.04.026 |
Ejemplares similares
-
An improved protocol to establish experimental tuberculous meningitis in the rabbit
por: O'Brien, Paul, et al.
Publicado: (2020) -
Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model
por: Kumar, Ranjeet, et al.
Publicado: (2020) -
Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis
por: Pouplin, Thomas, et al.
Publicado: (2016) -
Dexamethasone, Cerebrospinal Fluid Matrix Metalloproteinase Concentrations and Clinical Outcomes in Tuberculous Meningitis
por: Green, Justin A., et al.
Publicado: (2009) -
Estimation of cerebrospinal fluid cortisol level in tuberculous meningitis
por: Mahale, Rohan R., et al.
Publicado: (2015)